FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Actonel (risendronate sodium) by Allergan, Inc., under NDA 020835.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Actonel (risedronate)

Snippet

SUPPL AP for ACTONEL (RISEDRONATE SODIUM)